Pricing Log in Create free account
Friday 6 November 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue
+21.8%
EPS
−80.6%
Free cash flow
+6.78%

Quarter to September 2026, against a year earlier

45.12 0.58 +1.30%
Market cap
$7.5B
P/E
0.0×
Fwd P/E
−85.9×
Dividend yield
—
F-score
7/9
Altman Z
5.33
Beneish M
−3.29
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Alkermes plc (ALKS) Debt to equity

Alert me on Debt to equity

Alkermes plc's debt to equity at the end of the quarter to 30 September 2026 was 0.8×, up 0.8× from fiscal 2025 (0.0×). Over the past ten years it has ranged from 0.0× (fiscal 2025) to 0.3× (fiscal 2022) — the current reading is the lowest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 0.0× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.2× (13.99%)
FY2022 0.3× 5.68%
FY2021 0.3× 3.18%
FY2020 0.3× 0.94%
FY2019 0.3× 7.04%
FY2018 0.2× 1.92%
FY2017 0.2× (0.21%)
FY2016 0.2× (11.94%)

Quarterly newest first

Period Debt to equity Change
Sep 2026 0.8× (3.36%)
Jun 2026 0.8× (3.62%)
Mar 2026 0.9× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 0.3×
Ten-year median 0.2×
Current reading's percentile 18

Debt to equity against peers

Company Debt to equity
SUPN Indivior Pharmaceuticals Inc. compare −8.1×
KNSA Kiniksa Pharmaceuticals International, plc compare 0.0×
RDY Dr. Reddy's Laboratories Ltd compare 0.2×
LNTH Lantheus Holdings, Inc. compare 0.4×
ELAN Elanco Animal Health Incorporated compare 0.6×
ALKS Alkermes plc 0.8×
LQDA Liquidia Corporation compare 0.9×
HIMS Hims & Hers Health, Inc. compare 4.2×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 6.0×
Drug Manufacturers Specialty & Generic industry median 0.0×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on ALKS